Plain-English translation of NCT05828446 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a newer imaging method called abbreviated MRI can find liver cancer earlier and more accurately than the standard ultrasound screening that doctors currently use. Researchers want to understand which approach works best for people at risk of developing liver cancer due to chronic liver disease. The study will compare how well each imaging method detects cancer over time.
Currently, doctors use ultrasound to screen for early liver cancer in people with chronic liver disease, but this method sometimes misses small cancers. Researchers believe that a faster, simplified version of MRI scanning might catch more cancers earlier, which could save lives and improve treatment options.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic twice per year for screening appointments. During each visit, you would receive both an ultrasound and an MRI scan within the same week so the researchers can compare how well each method detects liver cancer. The study will track you over time to see which imaging approach finds cancers earlier and more reliably.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Switzerland
Naik Vietti Violi
Enrollment target
~330 participants
Started
April 2023
Primary completion
April 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Naik Vietti Violi, MD
University of Lausanne Hospitals
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.